Risks of drug interactions with St. John's Wort

被引：0

作者：

Ingram, KD ^{[1
]}

Dragosavac, GB ^{[1
]}

Benner, KG ^{[1
]}

Flora, KD ^{[1
]}

机构：

[1] Oregon Hlth Sci Univ, Div Gastroenterol Hepatol, Portland, OR 97201 USA

来源：

AMERICAN JOURNAL OF GASTROENTEROLOGY | 2000年 / 95卷 / 11期

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：3323 / 3324

页数：2

共 6 条

[1]

KATZUNG BG, 1998, BASIC CLIN PHARM

[2] Indinavir concentrations and St John's wort [J].

Piscitelli, SC ;

Burstein, AH ;

Chaitt, D ;

Alfaro, RM ;

Falloon, J .

LANCET, 2000, 355 (9203) :547-548

[3] St John's Wort: Effect on CYP3A4 activity [J].

Roby, CA ;

Anderson, GD ;

Kantor, E ;

Dryer, DA ;

Burstein, AH .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 67 (05) :451-457

[4] Acute heart transplant rejection due to Saint John's wort [J].

Ruschitzka, F ;

Meier, PJ ;

Turina, M ;

Lüscher, TF ;

Noll, G .

LANCET, 2000, 355 (9203) :548-549

[5]

*US FDA PUBL HLTH, 2000, RISK DRUG INT ST JOH

[6] Safety of St John's wort (Hypericum perforatum) [J].

Yue, QY ;

Bergquist, C ;

Gerdén, B .

LANCET, 2000, 355 (9203) :576-577

← 1 →